Matches in SemOpenAlex for { <https://semopenalex.org/work/W2909607407> ?p ?o ?g. }
- W2909607407 endingPage "1874" @default.
- W2909607407 startingPage "1859" @default.
- W2909607407 abstract "Hepatitis C virus (HCV) nucleoside inhibitors display pan-genotypic activity, a high barrier to the selection of resistant virus, and are some of the most potent direct-acting agents with durable sustained virologic response in humans. Herein, we report, the discovery of β-d-2'-Br,2'-F-uridine phosphoramidate diastereomers 27 and 28, as nontoxic pan-genotypic anti-HCV agents. Extensive profiling of these two phosphorous diastereomers was performed to select one for in-depth preclinical profiling. The 5'-triphosphate formed from these phosphoramidates selectively inhibited HCV NS5B polymerase with no inhibition of human polymerases and cellular mitochondrial RNA polymerase up to 100 μM. Both are nontoxic by a variety of measures and display good stability in human blood and favorable metabolism in human intestinal microsomes and liver microsomes. Ultimately, a preliminary oral pharmacokinetics study in male beagles showed that 28 is superior to 27 and is an attractive candidate for further studies to establish its potential value as a new clinical anti-HCV agent." @default.
- W2909607407 created "2019-01-25" @default.
- W2909607407 creator A5006809996 @default.
- W2909607407 creator A5010068737 @default.
- W2909607407 creator A5013511198 @default.
- W2909607407 creator A5019520337 @default.
- W2909607407 creator A5022810465 @default.
- W2909607407 creator A5029361950 @default.
- W2909607407 creator A5034965968 @default.
- W2909607407 creator A5039245540 @default.
- W2909607407 creator A5045509209 @default.
- W2909607407 creator A5051240459 @default.
- W2909607407 creator A5053355950 @default.
- W2909607407 creator A5058792872 @default.
- W2909607407 creator A5059191876 @default.
- W2909607407 creator A5060751697 @default.
- W2909607407 creator A5065232717 @default.
- W2909607407 creator A5069232388 @default.
- W2909607407 creator A5070268620 @default.
- W2909607407 creator A5072432194 @default.
- W2909607407 creator A5075818298 @default.
- W2909607407 creator A5079464117 @default.
- W2909607407 creator A5083338295 @default.
- W2909607407 creator A5087052821 @default.
- W2909607407 creator A5088309742 @default.
- W2909607407 creator A5090832501 @default.
- W2909607407 creator A5091702832 @default.
- W2909607407 date "2019-01-17" @default.
- W2909607407 modified "2023-09-27" @default.
- W2909607407 title "Discovery of a Series of 2′-α-Fluoro,2′-β-bromo-ribonucleosides and Their Phosphoramidate Prodrugs as Potent Pan-Genotypic Inhibitors of Hepatitis C Virus" @default.
- W2909607407 cites W1837246604 @default.
- W2909607407 cites W1936598828 @default.
- W2909607407 cites W1963623224 @default.
- W2909607407 cites W1964616708 @default.
- W2909607407 cites W1965852252 @default.
- W2909607407 cites W1969360633 @default.
- W2909607407 cites W1977139658 @default.
- W2909607407 cites W2001584279 @default.
- W2909607407 cites W2004371007 @default.
- W2909607407 cites W2009987166 @default.
- W2909607407 cites W2010150738 @default.
- W2909607407 cites W2012152582 @default.
- W2909607407 cites W2014290325 @default.
- W2909607407 cites W2016117318 @default.
- W2909607407 cites W2027545702 @default.
- W2909607407 cites W2045592358 @default.
- W2909607407 cites W2057325214 @default.
- W2909607407 cites W2059205366 @default.
- W2909607407 cites W2066449293 @default.
- W2909607407 cites W2079721684 @default.
- W2909607407 cites W2082772647 @default.
- W2909607407 cites W2131350133 @default.
- W2909607407 cites W2140880940 @default.
- W2909607407 cites W2148925357 @default.
- W2909607407 cites W2162658079 @default.
- W2909607407 cites W2163606686 @default.
- W2909607407 cites W2168912424 @default.
- W2909607407 cites W2294863049 @default.
- W2909607407 cites W2319911380 @default.
- W2909607407 cites W2329356889 @default.
- W2909607407 cites W2335084542 @default.
- W2909607407 cites W2346961068 @default.
- W2909607407 cites W2488521388 @default.
- W2909607407 cites W2498506208 @default.
- W2909607407 cites W2513359865 @default.
- W2909607407 cites W2619300495 @default.
- W2909607407 cites W2623670984 @default.
- W2909607407 cites W2762339476 @default.
- W2909607407 doi "https://doi.org/10.1021/acs.jmedchem.8b01300" @default.
- W2909607407 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/7722249" @default.
- W2909607407 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30653317" @default.
- W2909607407 hasPublicationYear "2019" @default.
- W2909607407 type Work @default.
- W2909607407 sameAs 2909607407 @default.
- W2909607407 citedByCount "11" @default.
- W2909607407 countsByYear W29096074072020 @default.
- W2909607407 countsByYear W29096074072021 @default.
- W2909607407 countsByYear W29096074072022 @default.
- W2909607407 countsByYear W29096074072023 @default.
- W2909607407 crossrefType "journal-article" @default.
- W2909607407 hasAuthorship W2909607407A5006809996 @default.
- W2909607407 hasAuthorship W2909607407A5010068737 @default.
- W2909607407 hasAuthorship W2909607407A5013511198 @default.
- W2909607407 hasAuthorship W2909607407A5019520337 @default.
- W2909607407 hasAuthorship W2909607407A5022810465 @default.
- W2909607407 hasAuthorship W2909607407A5029361950 @default.
- W2909607407 hasAuthorship W2909607407A5034965968 @default.
- W2909607407 hasAuthorship W2909607407A5039245540 @default.
- W2909607407 hasAuthorship W2909607407A5045509209 @default.
- W2909607407 hasAuthorship W2909607407A5051240459 @default.
- W2909607407 hasAuthorship W2909607407A5053355950 @default.
- W2909607407 hasAuthorship W2909607407A5058792872 @default.
- W2909607407 hasAuthorship W2909607407A5059191876 @default.
- W2909607407 hasAuthorship W2909607407A5060751697 @default.
- W2909607407 hasAuthorship W2909607407A5065232717 @default.
- W2909607407 hasAuthorship W2909607407A5069232388 @default.
- W2909607407 hasAuthorship W2909607407A5070268620 @default.
- W2909607407 hasAuthorship W2909607407A5072432194 @default.